Cargando…

Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non‐small cell lung cancer

AIMS: High expression of the RNA‐binding motif protein 3 (RBM3) correlates with improved prognosis in several major types of cancer. The aim of the present study was to examine the prognostic value of RBM3 protein and mRNA expression in non‐small cell lung cancer (NSCLC). METHODS AND RESULTS: Immuno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salomonsson, Annette, Micke, Patrick, Mattsson, Johanna S. M., La Fleur, Linnea, Isaksson, Johan, Jönsson, Mats, Nodin, Björn, Botling, Johan, Uhlén, Mathias, Jirström, Karin, Staaf, Johan, Planck, Maria, Brunnström, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402820/ https://www.ncbi.nlm.nih.gov/pubmed/32491279 http://dx.doi.org/10.1002/cam4.3149

Ejemplares similares

Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
por: Micke, Patrick, et al.
Publicado: (2019)

Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status
por: Planck, Maria, et al.
Publicado: (2013)

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
por: Nodin, Björn, et al.
Publicado: (2012)

CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
por: Isaksson, Sofi, et al.
Publicado: (2017)

Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study
por: Jonsson, Liv, et al.
Publicado: (2011)

Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer
por: Olofsson, Sven-Erik, et al.
Publicado: (2015)

Relation between smoking history and gene expression profiles in lung adenocarcinomas
por: Staaf, Johan, et al.
Publicado: (2012)

Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
por: Mattsson, Johanna S. M., et al.
Publicado: (2016)

Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer
por: Karlsson, Anna, et al.
Publicado: (2015)

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
por: Jonsson, Liv, et al.
Publicado: (2011)

High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death
por: Jonsson, Liv, et al.
Publicado: (2014)

Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
por: Lindquist, Kajsa Ericson, et al.
Publicado: (2017)

Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade
por: Eltahir, Mohamed, et al.
Publicado: (2021)

Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
por: Ehlén, Åsa, et al.
Publicado: (2010)

Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification
por: Karnevi, Emelie, et al.
Publicado: (2017)

PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
por: Goldmann, Torsten, et al.
Publicado: (2021)

Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer
por: Arbajian, Elsa, et al.
Publicado: (2020)

A gene expression‐based single sample predictor of lung adenocarcinoma molecular subtype and prognosis
por: Liljedahl, Helena, et al.
Publicado: (2020)

Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC—A retrospective single-center experience
por: Karadzovska-Kotevska, Marija, et al.
Publicado: (2022)

Oligonucleotide gap-fill ligation for mutation detection and sequencing in situ
por: Mignardi, Marco, et al.
Publicado: (2015)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
por: Wahlin, Sara, et al.
Publicado: (2022)

Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center
por: Isaksson, Sofi, et al.
Publicado: (2020)

Performance of gene expression–based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers: a case comparison study in non-small cell lung cancer
por: Cirenajwis, Helena, et al.
Publicado: (2019)

PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer
por: Olsson Hau, Sofie, et al.
Publicado: (2021)

Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series
por: Ericson-Lindquist, Kajsa, et al.
Publicado: (2017)

Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
por: Lundgren, Sebastian, et al.
Publicado: (2019)

Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
por: Rasmussen, Markus, et al.
Publicado: (2011)

A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer
por: Karlsson, Anna, et al.
Publicado: (2019)

Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data
por: Göransson, Hanna, et al.
Publicado: (2009)

The transcript interactome of skeletal muscle RNA binding protein motif 3 (RBM3)
por: Hettinger, Zachary R., et al.
Publicado: (2023)

Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
por: Boman, Karolina, et al.
Publicado: (2013)

Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study
por: Boman, Karolina, et al.
Publicado: (2017)

Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
por: Berntsson, Jonna, et al.
Publicado: (2014)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)

Correction to The transcript interactome of skeletal muscle RNA binding protein motif 3 (RBM3)
Publicado: (2023)

Identification of sample annotation errors in gene expression datasets
por: Lohr, Miriam, et al.
Publicado: (2015)

Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
por: Lundgren, Sebastian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uk7b3knilriir22f4afk0vhm9q